Will Xenon Pharmaceuticals Inc (XENE) Outperform the Rest of the Stocks in the Healthcare Sector?

Xenon Pharmaceuticals Inc (XENE) is near the top in its sector according to InvestorsObserver. XENE gets an overall rating of 94. That means it scores higher than 94% of stocks. Xenon Pharmaceuticals Inc gets a 87 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

XENE has an Overall Score of 94. Find out what this means to you and get the rest of the rankings on XENE!

See Full XENE Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 94 would rank higher than 94 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Xenon Pharmaceuticals Inc Stock Today?

Xenon Pharmaceuticals Inc (XENE) stock has fallen -2.51% while the S&P 500 is higher by 2.58% as of 3:37 PM on Friday, Jun 24. XENE has fallen -$0.79 from the previous closing price of $31.71 on volume of 1,192,171 shares. Over the past year the S&P 500 is down -8.74% while XENE is higher by 69.33%. XENE lost -$1.67 per share the over the last 12 months. Click Here to get the full Stock Report for Xenon Pharmaceuticals Inc stock.